About GERON CORP
Geron is a biotechnology company focused on developing innovative medicines for blood cancers, particularly myeloid hematologic malignancies, through pioneering research in telomerase inhibition. The company is driven by a mission to change the course of blood cancer and has a seasoned leadership team with expertise in research, clinical development, and commercialization.
Research and development of innovative medicines for myeloid hematologic malignanciesTelomerase inhibition as a therapeutic approachClinical trials and commercialization of therapies for blood cancers
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GERON CORP right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.